GlaxoSmithKline Acquires Developer Of Vaccine Platform Technologies

Main Category: Pharma Industry / Biotech Industry Also Included In: Immune System / Vaccines Article Date: 30 May 2013 - 0:00 PDT Pharmaceutical giant GlaxoSmithKline has just strengthened its vaccine business with the acquisition of Okairos AG, a developer of vaccine platform technologies, for 250 million .

http://www.medicalnewstoday.com/articles/261178.php

GlaxoSmithKline Acquires Developer Of Vaccine Platform Technologies

Pharmaceutical giant GlaxoSmithKline has just strengthened its vaccine business with the acquisition of Okairos AG, a developer of vaccine platform technologies, for 250 million .

http://www.medilexicon.com/medicalnews.php?newsid=261178